Back to search

University of Edinburgh

Investigating the impact of stress on accelerated ageing phenotypes and neuronal function

Abstract

dc:description.abstract

Stress is a fundamental biological process that enables individuals to respond adaptively to environmental challenges. However, when stress is prolonged or excessive, it can have detrimental effects. Chronic stress is a well-established risk factor for a range of physical and mental health conditions, contributing to the global healthcare burden. Central to the stress response is the release of glucocorticoids, namely cortisol in humans, the sustained elevation of which can lead to adverse outcomes. Understanding the mechanisms through which stress impacts health is therefore essential to inform the development of preventative or therapeutic strategies aimed at mitigating its negative effects. Given that stress is a known risk factor for age-related conditions and is linked to several hallmarks of ageing, including telomere shortening, epigenetic alterations and cellular senescence, it has been hypothesised that stress may exert its negative effect, in part, by accelerating ageing processes. Several approaches to quantify accelerated ageing in humans have been developed. One such method is based on predictable changes in DNA methylation (DNAm) at specific genomic sites, which are strongly associated with chronological age. This has led to the development of epigenetic clocks that estimate biological (or epigenetic) age. More recent generations of these clocks – such as, PhenoAge, GrimAge and GrimAge2 – are designed to better predict health-related outcomes. However, their relationship with stress measures remains to be fully elucidated. A similar approach involves the use of structural neuroimaging to estimate ‘brain age’. In both cases, the residuals obtained by regressing epigenetic or brain age on chronological age provide a measure of accelerated (positive residuals) or decelerated (negative residuals) ageing. These biomarkers offer valuable tools for investigating the link between stress and accelerated ageing. Another key mechanism through which stress may influence age-related health outcomes is by promoting systemic inflammation. While previous studies have linked stress to elevated levels of inflammatory markers, the extent to which stress is associated with a chronic-low grade inflammatory state - characteristic of ageing - remains to be fully explored. The first aim of this thesis is to investigate the relationship between hair glucocorticoids and phenotypic measures of stress with epigenetic and brain-based markers of accelerating ageing, inflammation and the circulating proteome. Hair glucocorticoids provide a more temporally stable marker of long-term glucocorticoid exposure. A DNAm-proxy of C-reactive protein (CRP) was used to explore the link between chronic low-grade inflammation and stress. Identifying robust biological markers of stress would significantly advance our understanding of the pathways connecting stress exposure to negative health outcomes. Thus, the relationships between stress measures and the circulating proteome were examined to identify candidate stress biomarkers. The second aim was to examine the longitudinal relationship between stress and epigenetic and brain markers of accelerated ageing. To better capture the cumulative burden of chronic stress, I used a composite index of physiological dysregulation known as allostatic load (AL). This index integrates biomarkers across multiple biological systems to reflect the cumulative physiological impact of chronic stress over time. The final aim of this thesis was to investigate the molecular impact of stress on the neuronal transcriptome and proteome using an in vitro model. The brain plays a central role in mediating the stress response, but the precise mechanisms through which stress impacts neuronal function remain incompletely understood. I also conducted an exploratory analysis of the overlap between stress-related proteins identified in blood and those differentially expressed in neurons following stress exposure. Biomarkers validated across both human cohort and cellular models would offer particularly strong evidence for their relevance and translational potential. In Chapter 2, I used validated questionnaire-based measures of both early (i.e., childhood trauma) and recent-life stress (i.e., psychological distress and stressful life events), alongside a measure of resilience – defined as the ability to recover from stress. Biological markers of long-term glucocorticoid exposure – hair cortisol, cortisone and their total – were also used. Hair glucocorticoids and self-reported stress measures were significantly associated with epigenetic age acceleration, though associations varied depending on the type of stressor and the specific epigenetic clock used. Stressful life events were significantly associated with accelerated brain ageing. Both biological and phenotypic stress indicators were associated with a chronic, low-grade inflammatory profile as indexed via a methylation-based proxy of CRP. To identify candidate stress biomarkers, associations between both hair glucocorticoids and phenotypic measures of stress and the circulating proteome were investigated. While no proteins were associated with hair glucocorticoids, 296 unique proteins were significantly associated with phenotypic stress measures. Approximately one third of these proteins were also associated with DNAm-based measures of accelerating ageing. These findings support the potential of circulating proteins as candidate biomarkers of stress and stress-related accelerated ageing. In Chapter 3, I found that higher levels of AL at baseline were associated with higher baseline levels of epigenetic age acceleration. Additionally, greater PhenoAge acceleration at baseline was associated with a steeper increase in AL over time. No associations were found between baseline or change in AL and the rate of change in brain age acceleration. Sex differences were observed, with females showing lower levels of both epigenetic and brain age acceleration at baseline, consistent with previous research. Glucocorticoids are lipophilic hormones capable of crossing the blood-brain barrier and exerting direct effects on brain function. Animal studies have shown that chronic glucocorticoid exposure impairs neurogenesis, reduces dendritic branching, inhibits synaptogenesis and induces behavioural phenotypes associated with stress-related disorders. Clinical research has similarly linked elevated cortisol levels to brain atrophy and cognitive decline. However, the molecular mechanism underlying glucocorticoid effects on the brain remain to be elucidated. Furthermore, previous studies have largely focused on transcriptomic changes, despite proteins being the primary cellular effectors. Chapter 4 aimed to elucidate the impact of glucocorticoid exposure on both the transcriptome and proteome of human neurons. I treated neurons derived from induced pluripotent stem cells with hydrocortisone, a glucocorticoid receptor agonist, and I assessed time-dependent transcriptional responses (6h and 24h) and proteomic responses (24h). Glucocorticoid treatment induced a robust neuronal stress response, with 291 and 370 differentially expressed genes at 6h and 24h, respectively and 451 differentially expressed proteins at 24h. Transcriptomic analysis revealed enrichment of pathways related to synaptic function and cellular senescence, while proteomic changes were enriched for energy metabolism and protein synthesis. Limited overlap was observed between transcriptomic and proteomic responses, or with candidate blood-based stress biomarkers identified in Chapter 2, potentially reflecting tissue-specific responses. Given the observed associations between stress measures and accelerated ageing in the previous chapter, along with the enrichment of senescence-related pathways - a recognised hallmark of ageing - in neurons exposed to glucocorticoids, future studies aimed at elucidating the role of stress in cellular senescence are warranted. Taken together, this thesis provides further evidence supporting the link between stress and accelerated ageing and highlights potential molecular mechanisms through which glucocorticoids may influence the human brain. Replication in independent cohorts is needed to establish the robustness of the associations reported in Chapters 2 and 3. Future research is required to validate and extend the findings presented in Chapter 4, with the broader aim of advancing our understanding of how stress negatively affects health, and supporting the development of preventative and/or therapeutic strategies for those most at risk.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Carr, Kevin
Advisors dc:contributor.advisor
  • Evans, Kathy
  • McCartney, Daniel
  • Russ, Tom
  • Spires-Jones, Tara
  • Marioni, Riccardo

Subjects

dc:subject × 5

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-20
Source record
OAI-PMH GetRecord
citation

Carr, Kevin. Investigating the impact of stress on accelerated ageing phenotypes and neuronal function. 2026. https://hdl.handle.net/1842/45537